“Byondis’ ambition is to become a leading pharmaceutical company by discovering, developing and delivering proprietary breakthrough medicinal modalities to patients in the field of cancer and other difficult to treat diseases. “
Jacques Lemmens, PhD, Founder / Chairman of the Board
Frequently Asked Questions (FAQ) for Investors
Is Byondis a privately owned company?
Byondis Holding B.V. is a private company with limited liability incorporated in the Netherlands. Byondis Holding and its subsidiaries, as a fully integrated biotech company, are mainly active in the field of research and development and production of innovative medicines.
When did Byondis begin operations?
Byondis started its biopharmaceutical activities in 2007 as Synthon Biopharmaceuticals, part of Synthon, a global leader in the development and manufacturing of complex generics. In 2012, the company became a new biopharmaceutical subsidiary and quickly built a promising pipeline of innovative research and development programs and rebranded itself as Byondis in April 2020.
Where is Byondis incorporated?
Byondis is incorporated in The Netherlands.
Where is Byondis headquartered?
Byondis is headquartered in Nijmegen, The Netherlands.
Registered address: Microweg 22 , 6545 CM Nijmegen, The Netherlands
Chamber of Commerce Byondis Holding: 10144473
Postal address:
P.O. Box 6570, 6503 GB Nijmegen, The Netherlands
What is Byondis’ fiscal year-end?
Byondis' fiscal year-end is December 31.
Who are Byondis’ independent auditors?
Byondis' independent auditors are Pricewaterhouse Coopers (PwC).
Where can I get the latest press releases?
Please visit our Press Release page on our Web site or sign-up for news alerts here.
Who should I contact if I have further questions?
Please contact Byondis’ investor relations at Investors@Byondis.com
Pipeline
Our diverse pipeline of proprietary next-generation ADCs reflects our expertise in research, lead identification, preclinical/clinical development, process development and manufacturing.
Who We Are
At Byondis, we are dedicated to transforming the lives of those affected by cancer.
